Indications and uses
Relieves occasional constipation (irregularity) Generally produces a bowel movement in 6-12 hours
Relieves occasional constipation (irregularity) Generally produces a bowel movement in 6-12 hours
Take preferably at bedtime or as directed by a doctor age starting dosage maximum dosage adults and children 12 years of age and over 2 tablets once a day 4 tablets twice a day children 6 to under 12 years 1 tablet once a day 2 tablets twice a day children 2 to under 6 years 1/2 tablet once a day 1 tablet twice a day children under 2 years ask a doctor ask a doctor
Docusate Sodium 50 mg
Sennosides 8.6 mg
Stool softener
Laxative
you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
| age | starting dosage | maximum dosage |
| adults and children
12 years of age and over | 2 tablets once a day | 4 tablets twice a day |
| children 6 to under 12 years | 1 tablet once a day | 2 tablets twice a day |
| children 2 to under 6 years | 1/2 tablet once a day | 1 tablet twice a day |
| children under 2 years | ask a doctor | ask a doctor |
croscarmellose sodium, dibasic calcium phosphate dihydrate, microcrystalline cellulose, pregelatinized starch, colloidal silicon dioxide, magnesium stearate, polyvinyl alcohol, titanium dioxide, polyethylene glycol (PEG) 3350, talc, FD&C red 40 lake, FD&C yellow 5 lake
NDC 63561-0187-01
Senna-S
DOCUSATE SODIUM 50 mg / STOOL SOFTENER
SENNOSIDES 8.6 mg / LAXATIVE
Compare to Senokot-S ®Dual Action Active Ingredients
100 Film-Coated Tablets
NDC 63561-0187-02
Senna-S
DOCUSATE SODIUM 50 mg / STOOL SOFTENER
SENNOSIDES 8.6 mg / LAXATIVE
Compare to Senokot-S ®Dual Action Active Ingredients
220 Film-Coated Tablets
NDC 63561-0187-03
Senna-S
DOCUSATE SODIUM 50 mg / STOOL SOFTENER
SENNOSIDES 8.6 mg / LAXATIVE
Compare to Senokot-S ®Dual Action Active Ingredients
1000 Film-Coated Tablets
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
| d723478e-ad4a-ec23-6bd7-cfe33e1e3840 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63561-0187-1 | Senna-S | 100 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 100 | 4 | |
| 63561-0187-2 | Senna-S | 220 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 220 | 4 | |
| 63561-0187-3 | Senna-S | 1000 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 1000 | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63561-0187 | 63561-0187-2, 63561-0187-1, 63561-0187-3 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Senna-S | DOCUSATE SODIUM, SENNOSIDES | Granulation Technology, Inc. | f36c509e-b93b-4d7f-a18a-41e585369a15 | 2025-07-30 | Warnings | 63561-0187-2 63561-0187-1 63561-0187-3 63561-0187 63561018703 63561018702 63561018701 3b28e1ec-d284-2f66-e063-6294a90aa7f1 f36c509e-b93b-4d7f-a18a-41e585369a15 |
Adverse event summaries are temporarily unavailable. Other product information remains available.